ALK’s partner, MSD, submits US license application for investigational house dust mite SLIT-tablet
February 10, 2016 02:30 ET
|
ALK Abello
Copenhagen, 2016-02-10 08:30 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) announced today that its partner for North America, MSD (known as Merck (NYSE: MRK) in the...
ALK and Abbott expand partnership into South-East Asian growth markets
January 28, 2016 02:30 ET
|
ALK Abello
Copenhagen, 2016-01-28 08:30 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced an expansion of its partnership with Abbott under which Abbott will register and sell...
ALK og Abbott udvider partnerskab med vækstmarkeder i Sydøstasien
January 28, 2016 02:30 ET
|
ALK Abello
København, 2016-01-28 08:30 CET (GLOBE NEWSWIRE) --
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at selskabet har udvidet partnerskabet med Abbott til at omfatte registrering...
Markedsføringstilladelse for ACARIZAX® udstedt i Frankrig
January 27, 2016 04:00 ET
|
ALK Abello
København, 2016-01-27 10:00 CET (GLOBE NEWSWIRE) --
Husstøvmider er den primære årsag til allergi i Frankrig, som er verdens største marked for sublingual...
Marketing authorisation for ACARIZAX® issued in France
January 27, 2016 04:00 ET
|
ALK Abello
Copenhagen, 2016-01-27 10:00 CET (GLOBE NEWSWIRE) --
House dust mites are the biggest cause of allergy in France, the world’s biggest sublingual allergy immunotherapy...
VALNEVA Announces Successful Establishment of New Global Marketing and Distribution Network
January 26, 2016 12:00 ET
|
VALNEVA
Valneva Announces Successful Establishment of New Global Marketing and Distribution Network IXIARO® marketing and distribution handover largely completed - excellent IXIARO® sales performance in...
VALNEVA établit avec succès son réseau de marketing et de distribution mondial
January 26, 2016 12:00 ET
|
VALNEVA
Valneva établit avec succès son réseau de marketing et de distribution mondial Transfert du marketing et de la distribution d'IXIARO® en grande partie achevé - excellente progression des ventes...
Meddelelse om ejerskab i ALK
January 15, 2016 11:34 ET
|
ALK Abello
København, 2016-01-15 17:34 CET (GLOBE NEWSWIRE) --
I henhold til § 29 i Lov om værdipapirhandel m.v. har ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) modtaget meddelelse fra Invesco Limited...
Notification of ownership in ALK
January 15, 2016 11:34 ET
|
ALK Abello
Copenhagen, 2016-01-15 17:34 CET (GLOBE NEWSWIRE) --
Pursuant to section 29 of the Danish Securities Trading Act, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has received notification from...
ALK announces top-line results from the five-year landmark GRAZAX® Asthma Prevention (GAP) trial in children
January 14, 2016 11:05 ET
|
ALK Abello
Copenhagen, 2016-01-14 17:05 CET (GLOBE NEWSWIRE) --
The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function.
The trial...